Results 181 to 190 of about 45,216 (237)

Supplementary materials and methods, supplement figure S1: to S12, and supplement table S1 from Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression

, 2023
Chiun Hsu, Liang‐In Lin, Yu‐Che Cheng, Zi-Rui Feng, Yu‐Yun Shao, Ann‐Lii Cheng, Da‐Liang Ou   +6 more
openalex   +1 more source

45 SORAFENIB IN CIRRHOTIC RATS: HEPATIC EFFECTS ASSOCIATED WITH THE BENEFICAL REDUCTION OF VASCULAR RESISTANCE AND PORTAL HYPERTENSION

, 2009
Martin Hennenberg, Jonel Trebicka, Zaki Kohistani, Christopher M. Stark, J Heller, Tilman Sauerbruch   +5 more
openalex   +1 more source

Supplemetary Figure S4 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis

, 2023
Francesca Fornari, Daniela Pollutri, Clarissa Patrizi, Tiziana La Bella, Sara Marinelli, Andrea Casadei‐Gardini, Giorgia Marisi, Marco Baron Toaldo, Michele Baglioni, Veronica Salvatore, Elisa Callegari, Maurizio Baldassarre, Marzia Galassi, Catia Giovannini, Matteo Cescon, Matteo Ravaioli, Massimo Negrini, Luigi Bolondi, Laura Gramantieri   +18 more
openalex   +1 more source

Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin/GPX4-Mediated Ferroptosis. [PDF]

Biomater Res
Feng W, Xu J, Chen B, Liu J, Hu Y, Cao X, Qi J, Ju L, Shao J, Dong P, Chen L, Wang F.   +11 more
europepmc   +1 more source

Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Liu R, Cui H, Li D, Guo X, Zhang Z, Tan S, Zhu X.   +6 more
europepmc   +1 more source

miR-199a-5p/GPR89A axis modulates sorafenib resistance in hepatocellular carcinoma through glutamate metabolic reprogramming. [PDF]

Sci Prog
Li Y, Cai Y, Duan G, Du Y, Hu J, Han X, Tang X, Jiang L, Ren J, Huo Q.   +9 more
europepmc   +1 more source

MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma. [PDF]

Int J Mol Sci
Leoni I, Galvani G, Monti E, Vianello C, Valenti F, Pincigher L, Grolla AA, Moro M, Coada CA, Perrone A, Righi V, Marinelli S, Ravegnini G, Giovannini C, Baldassarre M, Pariali M, Ravaioli M, Cescon M, Vasuri F, Domenicali M, Negrini M, Piscaglia F, Fato R, Stefanelli C, Gramantieri L, Bergamini C, Fornari F.   +26 more
europepmc   +1 more source

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity. [PDF]

Clin Transl Med
Wang X, Su Y, Lan B, Li X, Zhang B, Zhang L, Wang Y, Zhang C, Xuan C.   +8 more
europepmc   +1 more source

DDX42 Enhances Hepatocellular Carcinoma Cell Proliferation, Radiation and Sorafenib Resistance via Regulating GRB2 RNA Maturation and Activating PI3K/AKT Pathway. [PDF]

J Cell Mol Med
Liu Z, Yuan J, Liu F, Zeng Q, Wu Z, Yang J.   +5 more
europepmc   +1 more source

Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma [PDF]

, 2012
Sílvia Xargay‐Torrent, Mònica López‐Guerra, Arnau Montraveta, Ifigènia Saborit-Villarroya, Laia Rosich, Alba Navarro, Patricia Pérez‐Galán, Gaël Roué, Elı́as Campo, Dolors Colomer   +9 more
openalex   +1 more source